Search Results
Jul 08, 2025, 09:18 ET Cohen Milstein Sellers & Toll PLLC and Bernstein Litowitz Berger & Grossmann LLP Announce Pendency and Proposed Settlement of Class Action Involving All Persons and Entities who Purchased or Otherwise Acquired the Publicly Traded Common Stock and Preferred Stock of Silvergate Capital Corporation from November 7, 2019 through March 21, 2023, Inclusive or In and/or Traceable to Securities Offerings During 2021
Honorable James E. Simmons, Jr. either in person at the U.S. District Court for the Southern District of California, Edward J. Schwartz United States Courthouse, Courtroom 4B, 221 West Broadway, San Diego, CA 92101,
More news about: JND Legal Administration
Jul 08, 2025, 09:00 ET Velo3D Advances Strategic Partnership with Amaero Following Powder Qualification Milestone by Auburn University's NCAME
Velo3D production floor late in Q3CY2025 to support critical projects in the aerospace and defense industries." Hank J. Holland, Amaero Chairman and CEO, added:"To achieve the full potential of metal additive manufacturing, it's essential to build a
More news about: Velo3D, Inc.
Jul 08, 2025, 09:00 ET AI in Action: OpenText Empowers Knowledge Workers Across Industries with Personalized AI Productivity Tools
will introduce new paradigms of work, and deliver faster, smarter, and more personalized outcomes for our customers," said Mark J. Barrenechea, CEO & CTO, OpenText. "Our strategy is grounded in unifying organizations through secure information, service management, and
More news about: Open Text Corporation
Jul 08, 2025, 08:38 ET New SubjectWell Peer-Reviewed Paper Shows Digital Recruitment Can Expand Inclusion in Clinical Trials and Reduce Costs
https://hubs.ly/Q03qVZgZ0Full reference: Haas C, Klein L, Heckl M, Kesić M, Rueß AK, Gensichen J, Lukaschek K, Kruse T, POKAL-Group. Efficient Online Recruitment of Patients With Depressive Symptoms Using Social Media: Cross-Sectional Observational
More news about: SubjectWell
Jul 08, 2025, 08:20 ET MDVIP Expands in Upstate South Carolina with Two Family Medicine Practices in Greenville
with over 10 years of experience treating patients of all ages across the Upstate, has opened her MDVIP-affiliated practice at 420 The Parkway Suite J in Greer. Dr. Vejnar has a special interest in weight management, lifestyle medicine and aesthetics medicine. She maintains
More news about: MDVIP
Jul 08, 2025, 08:07 ET J.S. Held Acquires Chicago-based Turnaround & Restructuring Firm MorrisAnderson
Management (CRO, CEO, CFO, COO)Together, the team now includes over 75 professionals. MorrisAnderson Principal Mark J. Welch reflects on the expanded team, sharing, "The expertise at J.S. Held will be important to support our strong deal flow, enhancing our ability
More news about: J.S. Held
Jul 08, 2025, 08:01 ET Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)
Res. 1999 May;5(5):945-51 10. Basta NO, Halliday GC, Makin G, Birch J, Feltbower R, Bown N, et al. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. Br J Cancer. 2016;115:1048-57. 11. Desai A, et al. Outcomes Following GD2-Directed
More news about: Norgine
Jul 08, 2025, 08:00 ET Spark GHC and J ROC Development Announce Project Mustang, a New Hotel Development at Southpark Mall in Strongsville, Ohio
Spark GHC and J ROC Development are moving forward under a 50/50 joint venture post the recent signing of a purchase and sales agreement with the seller. Both firms bring deep local ties and strong development track records. Nick Catanzarite, principal at J ROC Development
More news about: Spark GHC
Jul 08, 2025, 08:00 ET Wilshire Boulevard Temple Deploys ZeroEyes to Mitigate Gun-Related Threats
SAFETY Act Designation, announced today that its proactive gun detection and intelligent situational awareness solution has been deployed by the Erika J. Glazer Family Campus of the Wilshire Boulevard Temple to protect members and staff against gun-related threats. Founded in 1862, it is the oldest Jewish
More news about: ZeroEyes
Jul 08, 2025, 08:00 ET Applied Aerospace Recognized for Contribution to NASA's Parker Solar Probe at Annual Collier Awards
Aerospace is honored to be recognized as a contributing partner to NASA's Parker Solar Probe mission, which has been awarded the prestigious 2024 Robert J. Collier Trophy by the National Aeronautic Association (NAA). Applied Aerospace was part of a team of companies that developed the record setting scientific
More news about: Applied Aerospace
Jul 08, 2025, 08:00 ET BRAEMAR HOTELS & RESORTS ANNOUNCES AGREEMENT TO SELL MARRIOTT SEATTLE WATERFRONT
May 31, 2025. "We are pleased to announce the planned sale of the Marriott Seattle Waterfront," said Richard J. Stockton, Braemar's president and CEO. "The sale of this upper upscale hotel will help deleverage our portfolio and further align our financial
More news about: Braemar Hotels & Resorts, Inc.
Jul 08, 2025, 08:00 ET Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo
2016;31(4)202-209. doi:10.1097/YIC.0000000000000125 iv Lafeuille MH, Gravel J, Lefebvre P, et al. Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics. J Med Econ. 2013;16(11):1290-1299. doi: 10.3111/13696998.2013.841705 v Birchwood,
More news about: Johnson & Johnson
Jul 08, 2025, 07:56 ET Antique Italian Sculpture Sells For More Than Nine Times High Estimate at Morphy's $2.7M Fine & Decorative Arts Auction
New York, active 1832-1847) Portrait of a Young Girl in a Green Dress took the spotlight. An oil-on-canvas signed J. Bradley, 128 Spring St. New York and stamped on verso with the phrase PREPARED BY THE O'KEEFE NEW
More news about: Morphy Auctions
Jul 08, 2025, 07:37 ET Cochlear Launches World's First and Only Smart Cochlear Implant System
Nel E, Del Dot J. Clinical outcomes with the Kanso™ off-the-ear cochlear implant sound processor. International Journal Of Audiology. 2017, Jan 9; 1-10. [Sponsored by Cochlear]7 Wolfe J, Neumann S, Marsh M, Schafer E, Lianos L, Gilden J, O'Neill L, Arkis
More news about: Cochlear North America
Jul 08, 2025, 07:30 ET Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
there is an unmet medical need, today issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber. The content of this letter is provided below.
More news about: SOLIGENIX, INC.
Jul 08, 2025, 07:01 ET New book discusses link between alternative equity and employee retention
incentives to business performance and create invested, committed key players without giving up ownership shares. Throughout the book, Buttenham and co-author J. Mark Poerio provide guidance for business owners who wish to develop flexible and effective incentive programs that foster
More news about: Reins
Jul 08, 2025, 07:00 ET UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community
controlled, multicentre Phase 3 trials. Lancet. 2024;403(10443):2504-19.Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158-164.Sabat R, Jemec GBE, Matusiak L, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.Lee
More news about: UCB
Jul 08, 2025, 06:37 ET Swissmedic approva IFINWIL® (eflornitina) per i bambini con diagnosi di neuroblastoma ad alto rischio (HRNB)
Res. 1999 May;5(5):945-51 10. Basta NO, Halliday GC, Makin G, Birch J, Feltbower R, Bown N, et al. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. Br J Cancer. 2016;115:1048-57. 11. Desai A, et al. Outcomes Following GD2-Directed
More news about: Norgine
Jul 08, 2025, 02:22 ET J&T Express Reports Q2 2025 Parcel Volume of 7.39 Billion; Southeast Asia Market Achieves Record Quarterly Growth of 65.9%
KONG, July 8, 2025 /PRNewswire/ -- J&T Global Express Limited ("J&T Express" or "J&T" or "the Company", stock code: 01519), a global logistics service provider, announced its key operating metrics
More news about: J&T EXPRESS
Jul 08, 2025, 02:01 ET Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)
Res. 1999 May;5(5):945-51 10. Basta NO, Halliday GC, Makin G, Birch J, Feltbower R, Bown N, et al. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. Br J Cancer. 2016;115:1048-57. 11. Desai A, et al. Outcomes Following GD2-Directed
More news about: Norgine
Jul 08, 2025, 02:01 ET Swissmedic lässt IFINWIL® (Eflornithin) für Kinder mit Hochrisiko-Neuroblastom (HRNB) zu
Res. 5. Mai 1999 (5):945-51 10. Basta NO, Halliday GC, Makin G, Birch J, Feltbower R, Bown N, et al. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. Br J Cancer. 2016;115:1048-57. 11. Desai A, et al. Outcomes Following GD2-Directed
More news about: Norgine
Jul 08, 2025, 02:01 ET Swissmedic approuve IFINWIL® (éflornithine) pour les enfants atteints de neuroblastome à haut risque
Res. 1999 May;5(5):945-51 10. Basta NO, Halliday GC, Makin G, Birch J, Feltbower R, Bown N, et al. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. Br J Cancer. 2016;115:1048-57. 11. Desai A, et al. Outcomes Following GD2-Directed
More news about: Norgine
Jul 08, 2025, 02:01 ET Swissmedic aprueba IFINWIL® (eflornitina) para niños diagnosticados con neuroblastoma de alto riesgo (HRNB)
Res. 1999 May;5(5):945-51 10. Basta NO, Halliday GC, Makin G, Birch J, Feltbower R, Bown N, et al. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. Br J Cancer. 2016;115:1048-57. 11. Desai A, et al. Outcomes Following GD2-Directed
More news about: Norgine
Jul 07, 2025, 18:58 ET Leading Medical Professional Societies, Patient Sue HHS, Robert F. Kennedy, Jr., for Unilateral Vaccine Changes
evidence-based resources to help patients make decisions grounded in facts, not fear. PLAINTIFF QUOTES: Susan J. Kressly, M.D., FAAP, President, AAP:"The American Academy of Pediatrics is alarmed by recent decisions by HHS to alter the routine
Jul 07, 2025, 16:17 ET Federated Hermes, Inc. announces second quarter 2025 earnings and conference call dates
9 a.m. Eastern on Friday, Aug. 1, 2025. President and Chief Executive Officer J. Christopher Donahue and Chief Financial Officer Thomas R. Donahue will host the call. Investors interested
More news about: Federated Hermes, Inc.